About the Startup
Novasign specializes in optimizing bioprocess development through modeling solutions, targeting various clients from biopharmaceuticals to academic research.
Source: https://brutkasten.com/artikel/novasign-wiener-biotech-startup-holt-millionen-investment-aus-den-usa
Frequently Asked Questions
What type of funding round did Novasign raise?
Novasign raised a unspecified round.
When did Novasign raise its unspecified?
Novasign raised its unspecified on 2025-09-04.
Who invested in Novasign's unspecified?
The investors in Novasign's unspecified are: Repligen Corporation.
What type of investment was Novasign's unspecified?
Novasign's unspecified was a equity investment.